Detailed Information on Publication Record
2021
Impact of Antibiotics Associated with the Development of Toxic Epidermal Necrolysis on Early and Late-Onset Infectious Complications
LIPOVÝ, Břetislav, Jakub HOLOUBEK, Marketa HANSLIANOVA, Michaela CVANOVÁ, Leo KLEIN et. al.Basic information
Original name
Impact of Antibiotics Associated with the Development of Toxic Epidermal Necrolysis on Early and Late-Onset Infectious Complications
Authors
LIPOVÝ, Břetislav (203 Czech Republic, belonging to the institution), Jakub HOLOUBEK (203 Czech Republic, belonging to the institution), Marketa HANSLIANOVA (203 Czech Republic), Michaela CVANOVÁ (203 Czech Republic, belonging to the institution), Leo KLEIN (203 Czech Republic), Ivana GROSSOVA (203 Czech Republic), Robert ZAJICEK, Peter BUKOVCAN (703 Slovakia), Jan KOLLER (703 Slovakia), Matus BARAN (703 Slovakia), Peter LENGYEL (703 Slovakia), Lukas EIMER (203 Czech Republic), Marie JANDOVA (203 Czech Republic), Milan KOSTAL (203 Czech Republic), Pavel BRYCHTA (203 Czech Republic, belonging to the institution) and Petra BOŘILOVÁ LINHARTOVÁ (203 Czech Republic, belonging to the institution)
Edition
Microorganisms, Basel, MDPI, 2021, 2076-2607
Other information
Language
English
Type of outcome
Článek v odborném periodiku
Field of Study
10606 Microbiology
Country of publisher
Switzerland
Confidentiality degree
není předmětem státního či obchodního tajemství
References:
Impact factor
Impact factor: 4.926
RIV identification code
RIV/00216224:14110/21:00121573
Organization unit
Faculty of Medicine
UT WoS
000610585100001
Keywords in English
toxic epidermal necrolysis; antibiotics; infectious complication; early-onset infection; late-onset infection
Tags
International impact, Reviewed
Změněno: 1/3/2022 09:56, Mgr. Tereza Miškechová
Abstract
V originále
Toxic epidermal necrolysis (TEN) is a rare disease, which predominantly manifests as damage to the skin and mucosa. Antibiotics count among the most common triggers of this hypersensitive reaction. Patients with TEN are highly susceptible to infectious complications due to the loss of protective barriers and immunosuppressant therapy. The aim of this study was to investigate the potential relationship between antibiotics used before the development of TEN and early and late-onset infectious complications in TEN patients. In this European multicentric retrospective study (Central European Lyell syndrome: therapeutic evaluation (CELESTE)), records showed that 18 patients with TEN used antibiotics (mostly aminopenicillins) before the disease development (group 1), while in 21 patients, TEN was triggered by another factor (group 2). The incidence of late-onset infectious complications (5 or more days after the transfer to the hospital) caused by Gram-positive bacteria (especially by Enterococcus faecalis/faecium) was significantly higher in group 1 than in group 2 (82.4% vs. 35.0%, p = 0.007/p(corr) = 0.014) while no statistically significant difference was observed between groups of patients with infection caused by Gram-negative bacteria, yeasts, and filamentous fungi (p > 0.05). Patients with post-antibiotic development of TEN are critically predisposed to late-onset infectious complications caused by Gram-positive bacteria, which may result from the dissemination of these bacteria from the primary focus.
Links
ROZV/28/LF5/2020, interní kód MU |
|